USE OF SIBUTRAMINE ANALOGUES TO PREVENT THE DEVELOPMENT OF DIABETES

USE OF SIBUTRAMINE ANALOGUES TO PREVENT THE DEVELOPMENT OF DIABETES

A COMPPOUND OF FORMULA 1 FORMULA 1 OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN WHICH R1 AND R2 ARE INDEPENDENTLY H OR METHYL(FOR EXAMPLE N,N-DIMETHYL-1-[1-(4-CHLOROPHENYL)CYCLOBUTYL]-3-METHYLBUTYL AMINE HYDROCHLORIDE OPTIONALLY IN THE FORM OF ITS MONOHYDRATE) IS USED FOR REDUCING INSULIN RESIST...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HELEN CHRISTINE JACKSON, ROBERT BRIAN JONES, CLIFFORD JAMES BAILEY
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A COMPPOUND OF FORMULA 1 FORMULA 1 OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN WHICH R1 AND R2 ARE INDEPENDENTLY H OR METHYL(FOR EXAMPLE N,N-DIMETHYL-1-[1-(4-CHLOROPHENYL)CYCLOBUTYL]-3-METHYLBUTYL AMINE HYDROCHLORIDE OPTIONALLY IN THE FORM OF ITS MONOHYDRATE) IS USED FOR REDUCING INSULIN RESISTANCE IN HUMANS IN WHOM IMPAIRED GLUCOSE TOLERANCE AND NON-INSULIN DEPENDENT DIABETES MELLITUS HAVE NOT PRESENTED.